Peptide Synthesis Market by Reagents (Resins, Amino Acid, Dyes), Equipment (Peptide Synthesizer, Chromatography, Lyophilizer), Technology (Solid-phase, Solution-phase, Hybrid), Services, End User (Pharma, Biotech, CRO), Region - Global Forecast to 2028
The global peptide synthesis market size is projected to reach USD 859 million by 2028 from 601 million in 2023, at a CAGR of 7.4 % during the forecast period. Factors such advancement in the field of peptide synthesis, and increased demand for reagents used in peptide synthesis is expected to experience steady growth leading to positive impact on the growth of peptide synthesis products & services.
“The reagents segment accounted for the highest growth rate in the peptide synthesis market, by product & service, during the forecast period”
In 2022, the reagents segment accounted for the highest growth rate. The peptide synthesis reagents market is further segmented into resins, amino acids, coupling reagents, dyes and fluorescent labeling reagents, and other reagents (such as protecting reagents, linkers, buffers, solvents, and solutions). The requirement of reagents in bulk quantities, expanding applications of peptides in therapeutics, drug design, and gene synthesis are some of the factors anticipated to project the growth of the segment.
“Asia Pacific region is likely to grow at a faster pace.”
The peptide synthesis market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the dominant share of the peptide synthesis market. The dominance of the region is attributable to various factors such as the presence of leading players in the region coupled with the ongoing research activities of developing new targeted therapies. Asia Pacific region is likely to grow at a faster pace owing to various factors such as the growing awareness of personalized therapeutics, rising government initiatives for generic medicines in the region, and the emergence of new market players in the peptide synthesis market.
The primary interviews conducted for this report can be categorized as follows:
This report provides a detailed picture of the peptide synthesis market. It aims at estimating the size and future growth potential of the market across different segments, such the product, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall peptide synthesis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
“The reagents segment accounted for the highest growth rate in the peptide synthesis market, by product & service, during the forecast period”
In 2022, the reagents segment accounted for the highest growth rate. The peptide synthesis reagents market is further segmented into resins, amino acids, coupling reagents, dyes and fluorescent labeling reagents, and other reagents (such as protecting reagents, linkers, buffers, solvents, and solutions). The requirement of reagents in bulk quantities, expanding applications of peptides in therapeutics, drug design, and gene synthesis are some of the factors anticipated to project the growth of the segment.
“Asia Pacific region is likely to grow at a faster pace.”
The peptide synthesis market is divided into North America, Europe, the Asia Pacific, Latin America, and the Middle East & Africa. In 2022, North America accounted for the dominant share of the peptide synthesis market. The dominance of the region is attributable to various factors such as the presence of leading players in the region coupled with the ongoing research activities of developing new targeted therapies. Asia Pacific region is likely to grow at a faster pace owing to various factors such as the growing awareness of personalized therapeutics, rising government initiatives for generic medicines in the region, and the emergence of new market players in the peptide synthesis market.
The primary interviews conducted for this report can be categorized as follows:
- By Respondent: Supply Side- 70%, and Demand Side - 30%
- By Designation (Supply Side): Managers - 45%, CXOs & Directors - 30%, Executives- 25%
- By Region: North America -40%, Europe -25%, Asia-Pacific -20%, Latin America -10%, and Middle East and Africa -5%
- Bachem Holding AG (Switzerland)
- Thermo Fisher Scientific, Inc. (US)
- Merck KGaA (Germany)
- GenScript Biotech Corporation (China)
- Kaneka Corporation (Japan)
- Biotage AB (Sweden)
- Syngene International Ltd. (India)
- Mesa Laboratories Inc. (US)
- CEM Corporation (US)
- ProteoGenix (France)
- Bio-Synthesis Inc. (US)
- Dalton Pharma Services (Canada)
- AAPPTec (US)
- vivitide (US)
- AnyGen Co., Ltd. (South Korea)
- CSBio (US)
- Advanced Chemtech (US)
- Luxembourg Bio Technologies Ltd. (Israel)
- JPT Peptide Technologies GmbH (Germany)
- AmbioPharm Inc. (US)
- Aurigene Pharmaceutical Services Ltd. (India)
- Corden Pharma International (Germany)
- ChemPep Inc. (US)
- CPC Scientific Inc. (US)
- Purolite Pvt Ltd. (US)
This report provides a detailed picture of the peptide synthesis market. It aims at estimating the size and future growth potential of the market across different segments, such the product, application, end user and region. The report also includes an in-depth competitive analysis of the key market players along with their company profiles recent developments and key market strategies.
Key Benefits of Buying the Report:
The report will help market leaders/new entrants by providing them with the closest approximations of the revenue numbers for the overall peptide synthesis market and its subsegments. It will also help stakeholders better understand the competitive landscape and gain more insights to better position their business and make suitable go-to-market strategies. This report will enable stakeholders to understand the market's pulse and provide them with information on the key market drivers, restraints, opportunities, and challenges.
The report provides insights on the following pointers:
- Analysis of key drivers (the increasing use of peptides in pharmaceutical drugs, increase in research activities and availability of funding for R&D, and the development of advanced automated peptide synthesizers), restraints (Lack of a unified set of regulations for therapeutic peptides, High cost of instruments), opportunities (Emerging markets in the Asia Pacific region, Development of personalized medicines), and challenges (Issues associated with the route of administration of peptide drugs, Addressing environmental impact of chemical synthesis of peptides.)
- Product & Service Development/Innovation: Detailed insights on newly launched products, and technological assessment of the peptide synthesis market.
- Market Development: Comprehensive information about lucrative markets – the report analyses the peptide synthesis market across varied regions.
- Market Diversification: Exhaustive information about new products & services, untapped geographies, recent developments, and investments in the peptide synthesis market.
- Competitive Assessment: In-depth assessment of market shares, growth strategies, and product & service offerings of leading players like GenScript Biotech Corporation (China), Thermo Fisher Scientific, Inc. (US), Bachem Holding AG (Switzerland), Kaneka Corporation (US), Inc.and Merck KGaA (Germany) and among others in the peptide synthesis market.
1 INTRODUCTION
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 PEPTIDE SYNTHESIS MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 3 PEPTIDE SYNTHESIS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE ANALYSIS, 2022
2.2.1 INSIGHTS FROM PRIMARIES
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
2.2.2 SEGMENT ASSESSMENT (BY PRODUCT, APPLICATION, AND END USER)
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 GROWTH RATE ASSUMPTIONS
FIGURE 8 PEPTIDE SYNTHESIS MARKET: CAGR PROJECTIONS, 2023–2028
FIGURE 9 PEPTIDE SYNTHESIS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 IMPACT OF ECONOMIC RECESSION ON PEPTIDE SYNTHESIS MARKET
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH)
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
3 EXECUTIVE SUMMARY
FIGURE 11 PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 12 PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
FIGURE 13 PEPTIDE SYNTHESIS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 14 PEPTIDE SYNTHESIS MARKET: GEOGRAPHICAL SNAPSHOT
4 PREMIUM INSIGHTS
4.1 PEPTIDE SYNTHESIS MARKET OVERVIEW
FIGURE 15 INCREASING USE OF PEPTIDES IN PHARMACEUTICAL DRUGS AND GROWING RESEARCH ACTIVITIES TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022)
FIGURE 16 REAGENTS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN PEPTIDE SYNTHESIS MARKET IN 2022
4.3 PEPTIDE SYNTHESIS MARKET SHARE, BY TECHNOLOGY (2022)
FIGURE 17 SOLID-PHASE PEPTIDE SYNTHESIS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.4 PEPTIDE SYNTHESIS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES WILL CONTINUE TO DOMINATE MARKET IN 2028
4.5 PEPTIDE SYNTHESIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 4 PEPTIDE SYNTHESIS MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Increasing use of peptides in pharmaceutical drugs
TABLE 5 PEPTIDE-BASED DRUGS APPROVED BY FOOD AND DRUG ADMINISTRATION
TABLE 6 KEY SYNTHETIC PEPTIDES IN DEVELOPMENT FOR COVID-19
5.2.1.2 Increase in research activities and availability of funding for R&D
FIGURE 21 RISE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026
5.2.1.3 Development of advanced automated peptide synthesizers
5.2.2 RESTRAINTS
5.2.2.1 Lack of unified set of regulations for therapeutic peptides
5.2.2.2 High cost of instruments
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets in Asia Pacific region
5.2.3.2 Development of personalized medicines
5.2.4 CHALLENGES
5.2.4.1 Issues associated with route of administration of peptide drugs
5.2.4.2 Addressing environmental impact of chemical synthesis of peptides
5.3 RANGES/SCENARIOS
FIGURE 22 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF PEPTIDE SYNTHESIS MARKET
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.5 VALUE CHAIN ANALYSIS
FIGURE 23 VALUE CHAIN ANALYSIS OF PEPTIDE SYNTHESIS MARKET: RESEARCH AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE
5.6 TECHNOLOGY ANALYSIS
TABLE 7 COMPARISON OF PEPTIDE SYNTHESIS TECHNOLOGIES
5.7 PATENT ANALYSIS
FIGURE 24 PATENT APPLICATIONS FOR PEPTIDE SYNTHESIS MARKET, JUNE 2013–JUNE 2023
TABLE 8 INDICATIVE LIST OF PATENTS IN PEPTIDE SYNTHESIS MARKET
5.8 ECOSYSTEM ANALYSIS OF PEPTIDE SYNTHESIS MARKET
TABLE 9 SUPPLY CHAIN ECOSYSTEM
5.9 PORTER’S FIVE FORCES ANALYSIS
TABLE 10 PEPTIDE SYNTHESIS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF SUPPLIERS
5.9.4 BARGAINING POWER OF BUYERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 REGULATORY ANALYSIS
5.10.1 REGULATIONS FOR PEPTIDE-BASED DRUGS
5.10.2 REGULATIONS FOR PEPTIDE SYNTHESIS PRODUCTS
5.10.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11 KEY CONFERENCES AND EVENTS IN 2023
TABLE 14 PEPTIDE SYNTHESIS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PEPTIDE SYNTHESIS PRODUCTS
5.12.2 BUYING CRITERIA
FIGURE 26 KEY BUYING CRITERIA FOR END USERS
6 PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 15 PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
6.2 REAGENTS
TABLE 16 PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 17 PEPTIDE SYNTHESIS REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 18 NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 19 EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 20 ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 21 LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.1 RESINS
6.2.1.1 Increasing adoption of solid-phase peptide synthesis technology to boost market
TABLE 22 PEPTIDE SYNTHESIS MARKET FOR RESINS, BY REGION, 2021–2028 (USD MILLION)
TABLE 23 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR RESINS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 24 EUROPE: PEPTIDE SYNTHESIS MARKET FOR RESINS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 25 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR RESINS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR RESINS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2 AMINO ACIDS
6.2.2.1 Amino acids play crucial role in synthesis of peptides
TABLE 27 PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY REGION, 2021–2028 (USD MILLION)
TABLE 28 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 29 EUROPE: PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 30 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 31 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.3 COUPLING REAGENTS
6.2.3.1 Vital role of coupling reagents in peptide bond formation to boost market
TABLE 32 PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 33 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 34 EUROPE: PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 35 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.4 DYES & FLUORESCENT LABELING REAGENTS
6.2.4.1 Fluorescent labeling reagents play crucial role in understanding success rate of peptide synthesis reactions
TABLE 37 PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 38 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 39 EUROPE: PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 40 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 41 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.5 OTHER REAGENTS
TABLE 42 PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 43 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 EUROPE: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 45 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 46 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 EQUIPMENT
TABLE 47 PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 48 PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 49 NORTH AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 50 EUROPE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 51 ASIA PACIFIC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 52 LATIN AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1 PEPTIDE SYNTHESIZERS
6.3.1.1 Rising automation in peptide synthesizers to drive market growth
TABLE 53 MAJOR PEPTIDE SYNTHESIZERS AVAILABLE IN MARKET
TABLE 54 PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 55 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 56 EUROPE: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 57 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2 CHROMATOGRAPHY EQUIPMENT
6.3.2.1 Reverse-phase HPLC used for purification of synthetic peptides to promote market growth
TABLE 59 PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY REGION, 2021–2028 (USD MILLION)
TABLE 60 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 61 EUROPE: PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 62 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 63 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.3 LYOPHILIZERS
6.3.3.1 Lyophilization to enable longer shelf life and easy transportation of peptides
TABLE 64 PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 65 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 66 EUROPE: PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 67 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 68 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 SERVICES
6.4.1 RISE IN RESEARCH ACTIVITIES IN PROTEOMICS, GENOMICS, AND PEPTIDE THERAPEUTICS TO DRIVE MARKET
TABLE 69 PEPTIDE SYNTHESIS SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 70 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 71 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 72 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 73 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
TABLE 74 PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
7.2 SOLID-PHASE PEPTIDE SYNTHESIS
7.2.1 EASE OF USE OF SOLID-PHASE PEPTIDE SYNTHESIS TECHNOLOGY TO DRIVE GROWTH
TABLE 75 SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 76 NORTH AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 77 EUROPE: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 78 ASIA PACIFIC: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 LATIN AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 SOLUTION-PHASE PEPTIDE SYNTHESIS
7.3.1 ABILITY TO PRODUCE LARGE QUANTITIES OF HIGH-QUALITY PEPTIDES COST-EFFECTIVELY TO DRIVE GROWTH
TABLE 80 SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 81 NORTH AMERICA: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 82 EUROPE: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 83 ASIA PACIFIC: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 84 LATIN AMERICA: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 HYBRID & RECOMBINANT TECHNOLOGY
7.4.1 PRODUCTION OF PEPTIDES WITH HIGH COMPLEXITY TO BOOST MARKET
TABLE 85 HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 86 NORTH AMERICA: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 87 EUROPE: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 88 ASIA PACIFIC: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 89 LATIN AMERICA: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
8 PEPTIDE SYNTHESIS MARKET, BY END USER
8.1 INTRODUCTION
TABLE 90 PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.2.1 USE OF PEPTIDES IN DRUG DEVELOPMENT APPLICATIONS TO DRIVE GROWTH
TABLE 91 PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 92 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 93 EUROPE: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 94 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 95 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS AND CONTRACT RESEARCH ORGANIZATIONS (CDMOS AND CROS)
8.3.1 INCREASING DEMAND FOR COST-EFFECTIVE PEPTIDE SYNTHESIS SERVICES TO DRIVE GROWTH
TABLE 96 PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY REGION, 2021–2028 (USD MILLION)
TABLE 97 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 98 EUROPE: PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 99 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 100 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 ACADEMIC & RESEARCH INSTITUTES
8.4.1 INCREASE IN FINANCIAL AND REGULATORY SUPPORT FOR RESEARCH TO BOOST MARKET GROWTH
TABLE 101 PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
TABLE 102 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 103 EUROPE: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 104 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 105 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
9 PEPTIDE SYNTHESIS MARKET, BY REGION
9.1 INTRODUCTION
TABLE 106 PEPTIDE SYNTHESIS MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET SNAPSHOT
TABLE 107 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 108 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 109 NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 110 NORTH AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 111 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 112 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.1 US
9.2.1.1 US to dominate North American peptide synthesis market during forecast period
TABLE 113 US: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 114 US: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 115 US: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 116 US: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 117 US: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Availability of research funding in Canada to drive market growth
TABLE 118 CANADA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 119 CANADA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 120 CANADA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 121 CANADA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 122 CANADA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3 EUROPE
TABLE 123 EUROPE: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 124 EUROPE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 125 EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 126 EUROPE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 127 EUROPE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 128 EUROPE: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Government initiatives and rise in funding for peptide synthesis to propel growth
TABLE 129 GERMANY: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 130 GERMANY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 131 GERMANY: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 132 GERMANY: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 133 GERMANY: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 USD MILLION)
9.3.2 UK
9.3.2.1 Growth in life science research to drive market growth
TABLE 134 UK: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 135 UK: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 136 UK: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 137 UK: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 138 UK: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Government funding for proteomics and genomics research to propel market growth
TABLE 139 FRANCE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 140 FRANCE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 141 FRANCE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 142 FRANCE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 143 FRANCE: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Increase in life science research to boost market growth in Italy
TABLE 144 ITALY: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 145 ITALY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 146 ITALY: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 147 ITALY: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 148 ITALY: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 USD MILLION)
9.3.5 SPAIN
9.3.5.1 Rising focus on research and innovation to support market growth
TABLE 149 SPAIN: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 150 SPAIN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 151 SPAIN: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 152 SPAIN: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 153 SPAIN: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 USD MILLION)
9.3.6 REST OF EUROPE
TABLE 154 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 155 REST OF EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 156 REST OF EUROPE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 157 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 158 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 28 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET SNAPSHOT
TABLE 159 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 160 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 161 ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 162 ASIA PACIFIC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 163 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 164 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.1 CHINA
9.4.1.1 China to register highest growth rate due to increase in investments in R&D
TABLE 165 CHINA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 166 CHINA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 167 CHINA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 168 CHINA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 169 CHINA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Rise in collaborations between companies in Japan to propel market growth
TABLE 170 JAPAN: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 171 JAPAN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 172 JAPAN: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 173 JAPAN: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 174 JAPAN: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Government support for scientific research to drive market growth
TABLE 175 INDIA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 176 INDIA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 177 INDIA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 178 INDIA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 179 INDIA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.4 SOUTH KOREA
9.4.4.1 Growing research efforts in biopharmaceutical sector to boost market growth
TABLE 180 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 181 SOUTH KOREA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 182 SOUTH KOREA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 183 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 184 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5 REST OF ASIA PACIFIC
TABLE 185 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 186 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 187 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 188 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 189 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6 LATIN AMERICA
TABLE 190 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 191 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 192 LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 193 LATIN AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 194 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 195 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6.1 BRAZIL
9.6.1.1 Rising government investments in research to propel market growth
TABLE 196 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 197 BRAZIL: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 198 BRAZIL: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 199 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 200 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6.2 MEXICO
9.6.2.1 Synthetic biology research advancements to drive market growth
TABLE 201 MEXICO: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 202 MEXICO: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 203 MEXICO: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 204 MEXICO: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 205 MEXICO: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6.3 REST OF LATIN AMERICA
TABLE 206 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 207 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 208 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 209 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 210 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6.4 MIDDLE EAST & AFRICA
9.6.4.1 Growing pharmaceutical & biotechnology industries and increasing R&D activities to drive market growth
TABLE 211 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 212 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 213 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 214 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 215 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 STRATEGIES ADOPTED BY KEY PLAYERS
FIGURE 29 PEPTIDE SYNTHESIS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
10.3 REVENUE SHARE ANALYSIS
FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022
10.4 MARKET SHARE ANALYSIS
FIGURE 31 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
TABLE 216 PEPTIDE SYNTHESIS MARKET: DEGREE OF COMPETITION
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
FIGURE 32 PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
10.6.1 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 217 PEPTIDE SYNTHESIS MARKET: PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
10.6.2 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 218 PEPTIDE SYNTHESIS MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
10.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES
FIGURE 33 PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
10.7.1 PROGRESSIVE COMPANIES
10.7.2 STARTING BLOCKS
10.7.3 RESPONSIVE COMPANIES
10.7.4 DYNAMIC COMPANIES
10.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
TABLE 219 PEPTIDE SYNTHESIS MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS
TABLE 220 PEPTIDE SYNTHESIS MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
10.9 COMPETITIVE SCENARIO AND TRENDS
10.9.1 PRODUCT LAUNCHES
TABLE 221 PEPTIDE SYNTHESIS MARKET: PRODUCT LAUNCHES, JANUARY 2020–JUNE 2023
10.9.2 DEALS
TABLE 222 PEPTIDE SYNTHESIS MARKET: DEALS, JANUARY 2020–JUNE 2023
10.9.3 OTHER DEVELOPMENTS
TABLE 223 PEPTIDE SYNTHESIS MARKET: OTHER DEVELOPMENTS, JANUARY 2020–JUNE 2023
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products & Services offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 THERMO FISHER SCIENTIFIC
TABLE 224 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 34 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022)
11.1.2 MERCK KGAA
TABLE 225 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2022)
11.1.3 GENSCRIPT BIOTECH CORPORATION
TABLE 226 GENSCRIPT BIOTECH CORPORATION: BUSINESS OVERVIEW
FIGURE 36 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2022)
11.1.4 BACHEM HOLDING AG
TABLE 227 BACHEM HOLDING AG: BUSINESS OVERVIEW
FIGURE 37 BACHEM HOLDING AG: COMPANY SNAPSHOT (2022)
11.1.5 KANEKA CORPORATION
TABLE 228 KANEKA CORPORATION: BUSINESS OVERVIEW
FIGURE 38 KANEKA CORPORATION: COMPANY SNAPSHOT (2022)
11.1.6 BIOTAGE AB
TABLE 229 BIOTAGE AB: BUSINESS OVERVIEW
FIGURE 39 BIOTAGE AB: COMPANY SNAPSHOT (2022)
11.1.7 SYNGENE INTERNATIONAL LIMITED
TABLE 230 SYNGENE INTERNATIONAL LIMITED: BUSINESS OVERVIEW
FIGURE 40 SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2022)
11.1.8 MESA LABORATORIES, INC.
TABLE 231 MESA LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 41 MESA LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
11.1.9 CEM CORPORATION
TABLE 232 CEM CORPORATION: BUSINESS OVERVIEW
11.1.10 PROTEOGENIX
TABLE 233 PROTEOGENIX: BUSINESS OVERVIEW
11.1.11 BIO-SYNTHESIS INC.
TABLE 234 BIO-SYNTHESIS INC.: BUSINESS OVERVIEW
11.1.12 DALTON PHARMA SERVICES
TABLE 235 DALTON PHARMA SERVICES: BUSINESS OVERVIEW
11.1.13 AAPPTEC
TABLE 236 AAPPTEC: BUSINESS OVERVIEW
11.1.14 VIVITIDE
TABLE 237 VIVITIDE: BUSINESS OVERVIEW
11.1.15 ANYGEN CO., LTD.
TABLE 238 ANYGEN CO., LTD.: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 CSBIO
11.2.2 ADVANCED CHEMTECH
11.2.3 LUXEMBOURG BIO TECHNOLOGIES LTD.
11.2.4 JPT PEPTIDE TECHNOLOGIES GMBH
11.2.5 AMBIOPHARM INC.
11.2.6 AURIGENE PHARMACEUTICAL SERVICES LTD.
11.2.7 CORDENPHARMA INTERNATIONAL
11.2.8 CHEMPEP INC.
11.2.9 CPC SCIENTIFIC INC.
11.2.10 PUROLITE PVT. LTD.
*Details on Business Overview, Products & Services offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
1.1 STUDY OBJECTIVES
1.2 MARKET DEFINITION
1.2.1 INCLUSIONS & EXCLUSIONS
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED
1.4 CURRENCY CONSIDERED
1.5 LIMITATIONS
1.6 STAKEHOLDERS
1.7 SUMMARY OF CHANGES
1.7.1 RECESSION IMPACT
2 RESEARCH METHODOLOGY
2.1 RESEARCH DATA
FIGURE 1 RESEARCH DESIGN
2.1.1 SECONDARY DATA
2.1.2 PRIMARY DATA
FIGURE 2 PEPTIDE SYNTHESIS MARKET: BREAKDOWN OF PRIMARIES
2.2 MARKET SIZE ESTIMATION
FIGURE 3 PEPTIDE SYNTHESIS MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2022
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (REVENUE SHARE ANALYSIS), 2022
FIGURE 5 ILLUSTRATIVE EXAMPLE OF THERMO FISHER SCIENTIFIC, INC.: REVENUE SHARE ANALYSIS, 2022
2.2.1 INSIGHTS FROM PRIMARIES
FIGURE 6 MARKET VALIDATION FROM PRIMARY EXPERTS
2.2.2 SEGMENT ASSESSMENT (BY PRODUCT, APPLICATION, AND END USER)
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
2.3 GROWTH RATE ASSUMPTIONS
FIGURE 8 PEPTIDE SYNTHESIS MARKET: CAGR PROJECTIONS, 2023–2028
FIGURE 9 PEPTIDE SYNTHESIS MARKET: GROWTH ANALYSIS OF DRIVERS, RESTRAINTS, CHALLENGES, AND OPPORTUNITIES
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION
FIGURE 10 DATA TRIANGULATION METHODOLOGY
2.5 STUDY ASSUMPTIONS
2.6 RISK ANALYSIS
2.7 IMPACT OF ECONOMIC RECESSION ON PEPTIDE SYNTHESIS MARKET
TABLE 1 GLOBAL INFLATION RATE PROJECTIONS, 2021–2028 (% GROWTH)
TABLE 2 US HEALTH EXPENDITURE, 2019–2022 (USD MILLION)
TABLE 3 US HEALTH EXPENDITURE, 2023–2027 (USD MILLION)
3 EXECUTIVE SUMMARY
FIGURE 11 PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2023 VS. 2028 (USD MILLION)
FIGURE 12 PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2023 VS. 2028 (USD MILLION)
FIGURE 13 PEPTIDE SYNTHESIS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 14 PEPTIDE SYNTHESIS MARKET: GEOGRAPHICAL SNAPSHOT
4 PREMIUM INSIGHTS
4.1 PEPTIDE SYNTHESIS MARKET OVERVIEW
FIGURE 15 INCREASING USE OF PEPTIDES IN PHARMACEUTICAL DRUGS AND GROWING RESEARCH ACTIVITIES TO DRIVE MARKET GROWTH
4.2 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE AND COUNTRY (2022)
FIGURE 16 REAGENTS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN PEPTIDE SYNTHESIS MARKET IN 2022
4.3 PEPTIDE SYNTHESIS MARKET SHARE, BY TECHNOLOGY (2022)
FIGURE 17 SOLID-PHASE PEPTIDE SYNTHESIS SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2022
4.4 PEPTIDE SYNTHESIS MARKET, BY END USER, 2023 VS. 2028 (USD MILLION)
FIGURE 18 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES WILL CONTINUE TO DOMINATE MARKET IN 2028
4.5 PEPTIDE SYNTHESIS MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES
FIGURE 19 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH DURING FORECAST PERIOD
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
FIGURE 20 MARKET DYNAMICS: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES
TABLE 4 PEPTIDE SYNTHESIS MARKET: IMPACT ANALYSIS
5.2.1 DRIVERS
5.2.1.1 Increasing use of peptides in pharmaceutical drugs
TABLE 5 PEPTIDE-BASED DRUGS APPROVED BY FOOD AND DRUG ADMINISTRATION
TABLE 6 KEY SYNTHETIC PEPTIDES IN DEVELOPMENT FOR COVID-19
5.2.1.2 Increase in research activities and availability of funding for R&D
FIGURE 21 RISE IN GLOBAL PHARMACEUTICAL R&D SPENDING, 2012–2026
5.2.1.3 Development of advanced automated peptide synthesizers
5.2.2 RESTRAINTS
5.2.2.1 Lack of unified set of regulations for therapeutic peptides
5.2.2.2 High cost of instruments
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets in Asia Pacific region
5.2.3.2 Development of personalized medicines
5.2.4 CHALLENGES
5.2.4.1 Issues associated with route of administration of peptide drugs
5.2.4.2 Addressing environmental impact of chemical synthesis of peptides
5.3 RANGES/SCENARIOS
FIGURE 22 SPECTRUM OF SCENARIOS BASED ON IMPACT OF UNCERTAINTIES ON GROWTH OF PEPTIDE SYNTHESIS MARKET
5.4 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES
5.5 VALUE CHAIN ANALYSIS
FIGURE 23 VALUE CHAIN ANALYSIS OF PEPTIDE SYNTHESIS MARKET: RESEARCH AND MANUFACTURING PHASE CONTRIBUTES MAXIMUM VALUE
5.6 TECHNOLOGY ANALYSIS
TABLE 7 COMPARISON OF PEPTIDE SYNTHESIS TECHNOLOGIES
5.7 PATENT ANALYSIS
FIGURE 24 PATENT APPLICATIONS FOR PEPTIDE SYNTHESIS MARKET, JUNE 2013–JUNE 2023
TABLE 8 INDICATIVE LIST OF PATENTS IN PEPTIDE SYNTHESIS MARKET
5.8 ECOSYSTEM ANALYSIS OF PEPTIDE SYNTHESIS MARKET
TABLE 9 SUPPLY CHAIN ECOSYSTEM
5.9 PORTER’S FIVE FORCES ANALYSIS
TABLE 10 PEPTIDE SYNTHESIS MARKET: PORTER’S FIVE FORCES ANALYSIS
5.9.1 THREAT OF NEW ENTRANTS
5.9.2 THREAT OF SUBSTITUTES
5.9.3 BARGAINING POWER OF SUPPLIERS
5.9.4 BARGAINING POWER OF BUYERS
5.9.5 INTENSITY OF COMPETITIVE RIVALRY
5.10 REGULATORY ANALYSIS
5.10.1 REGULATIONS FOR PEPTIDE-BASED DRUGS
5.10.2 REGULATIONS FOR PEPTIDE SYNTHESIS PRODUCTS
5.10.3 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 11 NORTH AMERICA: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 12 EUROPE: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
TABLE 13 ASIA PACIFIC: LIST OF REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS
5.11 KEY CONFERENCES AND EVENTS IN 2023
TABLE 14 PEPTIDE SYNTHESIS MARKET: DETAILED LIST OF CONFERENCES AND EVENTS IN 2023
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA
5.12.1 KEY STAKEHOLDERS IN BUYING PROCESS
FIGURE 25 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PEPTIDE SYNTHESIS PRODUCTS
5.12.2 BUYING CRITERIA
FIGURE 26 KEY BUYING CRITERIA FOR END USERS
6 PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE
6.1 INTRODUCTION
TABLE 15 PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
6.2 REAGENTS
TABLE 16 PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 17 PEPTIDE SYNTHESIS REAGENTS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 18 NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 19 EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 20 ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 21 LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.1 RESINS
6.2.1.1 Increasing adoption of solid-phase peptide synthesis technology to boost market
TABLE 22 PEPTIDE SYNTHESIS MARKET FOR RESINS, BY REGION, 2021–2028 (USD MILLION)
TABLE 23 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR RESINS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 24 EUROPE: PEPTIDE SYNTHESIS MARKET FOR RESINS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 25 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR RESINS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 26 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR RESINS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.2 AMINO ACIDS
6.2.2.1 Amino acids play crucial role in synthesis of peptides
TABLE 27 PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY REGION, 2021–2028 (USD MILLION)
TABLE 28 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 29 EUROPE: PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 30 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 31 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR AMINO ACIDS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.3 COUPLING REAGENTS
6.2.3.1 Vital role of coupling reagents in peptide bond formation to boost market
TABLE 32 PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 33 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 34 EUROPE: PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 35 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 36 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR COUPLING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.4 DYES & FLUORESCENT LABELING REAGENTS
6.2.4.1 Fluorescent labeling reagents play crucial role in understanding success rate of peptide synthesis reactions
TABLE 37 PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 38 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 39 EUROPE: PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 40 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 41 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR DYES & FLUORESCENT LABELING REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.2.5 OTHER REAGENTS
TABLE 42 PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY REGION, 2021–2028 (USD MILLION)
TABLE 43 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 44 EUROPE: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 45 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 46 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR OTHER REAGENTS, BY COUNTRY, 2021–2028 (USD MILLION)
6.3 EQUIPMENT
TABLE 47 PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 48 PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 49 NORTH AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 50 EUROPE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 51 ASIA PACIFIC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 52 LATIN AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.1 PEPTIDE SYNTHESIZERS
6.3.1.1 Rising automation in peptide synthesizers to drive market growth
TABLE 53 MAJOR PEPTIDE SYNTHESIZERS AVAILABLE IN MARKET
TABLE 54 PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 55 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 56 EUROPE: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 57 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 58 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PEPTIDE SYNTHESIZERS, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.2 CHROMATOGRAPHY EQUIPMENT
6.3.2.1 Reverse-phase HPLC used for purification of synthetic peptides to promote market growth
TABLE 59 PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY REGION, 2021–2028 (USD MILLION)
TABLE 60 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 61 EUROPE: PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 62 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 63 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CHROMATOGRAPHY EQUIPMENT, BY COUNTRY, 2021–2028 (USD MILLION)
6.3.3 LYOPHILIZERS
6.3.3.1 Lyophilization to enable longer shelf life and easy transportation of peptides
TABLE 64 PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY REGION, 2021–2028 (USD MILLION)
TABLE 65 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 66 EUROPE: PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 67 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 68 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR LYOPHILIZERS, BY COUNTRY, 2021–2028 (USD MILLION)
6.4 SERVICES
6.4.1 RISE IN RESEARCH ACTIVITIES IN PROTEOMICS, GENOMICS, AND PEPTIDE THERAPEUTICS TO DRIVE MARKET
TABLE 69 PEPTIDE SYNTHESIS SERVICES MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 70 NORTH AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 71 EUROPE: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 72 ASIA PACIFIC: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 73 LATIN AMERICA: PEPTIDE SYNTHESIS SERVICES MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7 PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY
7.1 INTRODUCTION
TABLE 74 PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
7.2 SOLID-PHASE PEPTIDE SYNTHESIS
7.2.1 EASE OF USE OF SOLID-PHASE PEPTIDE SYNTHESIS TECHNOLOGY TO DRIVE GROWTH
TABLE 75 SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 76 NORTH AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 77 EUROPE: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 78 ASIA PACIFIC: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 79 LATIN AMERICA: SOLID-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.3 SOLUTION-PHASE PEPTIDE SYNTHESIS
7.3.1 ABILITY TO PRODUCE LARGE QUANTITIES OF HIGH-QUALITY PEPTIDES COST-EFFECTIVELY TO DRIVE GROWTH
TABLE 80 SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 81 NORTH AMERICA: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 82 EUROPE: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 83 ASIA PACIFIC: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 84 LATIN AMERICA: SOLUTION-PHASE PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
7.4 HYBRID & RECOMBINANT TECHNOLOGY
7.4.1 PRODUCTION OF PEPTIDES WITH HIGH COMPLEXITY TO BOOST MARKET
TABLE 85 HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY REGION, 2021–2028 (USD MILLION)
TABLE 86 NORTH AMERICA: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 87 EUROPE: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 88 ASIA PACIFIC: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 89 LATIN AMERICA: HYBRID & RECOMBINANT PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
8 PEPTIDE SYNTHESIS MARKET, BY END USER
8.1 INTRODUCTION
TABLE 90 PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
8.2 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.2.1 USE OF PEPTIDES IN DRUG DEVELOPMENT APPLICATIONS TO DRIVE GROWTH
TABLE 91 PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2021–2028 (USD MILLION)
TABLE 92 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 93 EUROPE: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 94 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 95 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY COUNTRY, 2021–2028 (USD MILLION)
8.3 CONTRACT DEVELOPMENT & MANUFACTURING ORGANIZATIONS AND CONTRACT RESEARCH ORGANIZATIONS (CDMOS AND CROS)
8.3.1 INCREASING DEMAND FOR COST-EFFECTIVE PEPTIDE SYNTHESIS SERVICES TO DRIVE GROWTH
TABLE 96 PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY REGION, 2021–2028 (USD MILLION)
TABLE 97 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 98 EUROPE: PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 99 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 100 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR CDMOS AND CROS, BY COUNTRY, 2021–2028 (USD MILLION)
8.4 ACADEMIC & RESEARCH INSTITUTES
8.4.1 INCREASE IN FINANCIAL AND REGULATORY SUPPORT FOR RESEARCH TO BOOST MARKET GROWTH
TABLE 101 PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2021–2028 (USD MILLION)
TABLE 102 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 103 EUROPE: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 104 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 105 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET FOR ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2021–2028 (USD MILLION)
9 PEPTIDE SYNTHESIS MARKET, BY REGION
9.1 INTRODUCTION
TABLE 106 PEPTIDE SYNTHESIS MARKET, BY REGION, 2021–2028 (USD MILLION)
9.2 NORTH AMERICA
FIGURE 27 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET SNAPSHOT
TABLE 107 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 108 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 109 NORTH AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 110 NORTH AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 111 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 112 NORTH AMERICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.1 US
9.2.1.1 US to dominate North American peptide synthesis market during forecast period
TABLE 113 US: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 114 US: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 115 US: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 116 US: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 117 US: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.2.2 CANADA
9.2.2.1 Availability of research funding in Canada to drive market growth
TABLE 118 CANADA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 119 CANADA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 120 CANADA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 121 CANADA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 122 CANADA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3 EUROPE
TABLE 123 EUROPE: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 124 EUROPE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 125 EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 126 EUROPE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 127 EUROPE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 128 EUROPE: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.1 GERMANY
9.3.1.1 Government initiatives and rise in funding for peptide synthesis to propel growth
TABLE 129 GERMANY: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 130 GERMANY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 131 GERMANY: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 132 GERMANY: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 133 GERMANY: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 USD MILLION)
9.3.2 UK
9.3.2.1 Growth in life science research to drive market growth
TABLE 134 UK: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 135 UK: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 136 UK: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 137 UK: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 138 UK: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.3 FRANCE
9.3.3.1 Government funding for proteomics and genomics research to propel market growth
TABLE 139 FRANCE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 140 FRANCE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 141 FRANCE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 142 FRANCE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 143 FRANCE: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.3.4 ITALY
9.3.4.1 Increase in life science research to boost market growth in Italy
TABLE 144 ITALY: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 145 ITALY: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 146 ITALY: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 147 ITALY: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 148 ITALY: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 USD MILLION)
9.3.5 SPAIN
9.3.5.1 Rising focus on research and innovation to support market growth
TABLE 149 SPAIN: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 150 SPAIN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 151 SPAIN: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 152 SPAIN: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 153 SPAIN: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 USD MILLION)
9.3.6 REST OF EUROPE
TABLE 154 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 155 REST OF EUROPE: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 156 REST OF EUROPE: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 157 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 158 REST OF EUROPE: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4 ASIA PACIFIC
FIGURE 28 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET SNAPSHOT
TABLE 159 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 160 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 161 ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 162 ASIA PACIFIC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 163 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 164 ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.1 CHINA
9.4.1.1 China to register highest growth rate due to increase in investments in R&D
TABLE 165 CHINA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 166 CHINA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 167 CHINA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 168 CHINA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 169 CHINA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.2 JAPAN
9.4.2.1 Rise in collaborations between companies in Japan to propel market growth
TABLE 170 JAPAN: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 171 JAPAN: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 172 JAPAN: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 173 JAPAN: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 174 JAPAN: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.3 INDIA
9.4.3.1 Government support for scientific research to drive market growth
TABLE 175 INDIA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 176 INDIA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 177 INDIA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 178 INDIA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 179 INDIA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.4.4 SOUTH KOREA
9.4.4.1 Growing research efforts in biopharmaceutical sector to boost market growth
TABLE 180 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 181 SOUTH KOREA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 182 SOUTH KOREA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 183 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 184 SOUTH KOREA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.5 REST OF ASIA PACIFIC
TABLE 185 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 186 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 187 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 188 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 189 REST OF ASIA PACIFIC: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6 LATIN AMERICA
TABLE 190 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY COUNTRY, 2021–2028 (USD MILLION)
TABLE 191 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 192 LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 193 LATIN AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 194 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 195 LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6.1 BRAZIL
9.6.1.1 Rising government investments in research to propel market growth
TABLE 196 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 197 BRAZIL: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 198 BRAZIL: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 199 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 200 BRAZIL: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6.2 MEXICO
9.6.2.1 Synthetic biology research advancements to drive market growth
TABLE 201 MEXICO: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 202 MEXICO: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 203 MEXICO: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 204 MEXICO: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 205 MEXICO: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6.3 REST OF LATIN AMERICA
TABLE 206 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 207 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 208 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 209 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 210 REST OF LATIN AMERICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
9.6.4 MIDDLE EAST & AFRICA
9.6.4.1 Growing pharmaceutical & biotechnology industries and increasing R&D activities to drive market growth
TABLE 211 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY PRODUCT & SERVICE, 2021–2028 (USD MILLION)
TABLE 212 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS REAGENTS MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 213 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS EQUIPMENT MARKET, BY TYPE, 2021–2028 (USD MILLION)
TABLE 214 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY TECHNOLOGY, 2021–2028 (USD MILLION)
TABLE 215 MIDDLE EAST & AFRICA: PEPTIDE SYNTHESIS MARKET, BY END USER, 2021–2028 (USD MILLION)
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 STRATEGIES ADOPTED BY KEY PLAYERS
FIGURE 29 PEPTIDE SYNTHESIS MARKET: STRATEGIES ADOPTED BY KEY PLAYERS
10.3 REVENUE SHARE ANALYSIS
FIGURE 30 REVENUE ANALYSIS OF KEY PLAYERS, 2020–2022
10.4 MARKET SHARE ANALYSIS
FIGURE 31 MARKET SHARE ANALYSIS OF KEY PLAYERS, 2022
TABLE 216 PEPTIDE SYNTHESIS MARKET: DEGREE OF COMPETITION
10.5 COMPANY EVALUATION MATRIX: KEY PLAYERS
FIGURE 32 PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION MATRIX FOR KEY PLAYERS, 2022
10.5.1 STARS
10.5.2 EMERGING LEADERS
10.5.3 PERVASIVE PLAYERS
10.5.4 PARTICIPANTS
10.6 COMPETITIVE BENCHMARKING OF TOP 25 PLAYERS
10.6.1 PRODUCT FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 217 PEPTIDE SYNTHESIS MARKET: PRODUCT FOOTPRINT ANALYSIS OF KEY PLAYERS
10.6.2 REGIONAL FOOTPRINT OF COMPANIES (25 COMPANIES)
TABLE 218 PEPTIDE SYNTHESIS MARKET: REGIONAL FOOTPRINT ANALYSIS OF KEY PLAYERS
10.7 COMPANY EVALUATION QUADRANT: START-UPS/SMES
FIGURE 33 PEPTIDE SYNTHESIS MARKET: COMPANY EVALUATION MATRIX FOR START-UPS/SMES, 2022
10.7.1 PROGRESSIVE COMPANIES
10.7.2 STARTING BLOCKS
10.7.3 RESPONSIVE COMPANIES
10.7.4 DYNAMIC COMPANIES
10.8 COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
TABLE 219 PEPTIDE SYNTHESIS MARKET: DETAILED LIST OF KEY START-UP/SME PLAYERS
TABLE 220 PEPTIDE SYNTHESIS MARKET: COMPETITIVE BENCHMARKING OF START-UP/SME PLAYERS
10.9 COMPETITIVE SCENARIO AND TRENDS
10.9.1 PRODUCT LAUNCHES
TABLE 221 PEPTIDE SYNTHESIS MARKET: PRODUCT LAUNCHES, JANUARY 2020–JUNE 2023
10.9.2 DEALS
TABLE 222 PEPTIDE SYNTHESIS MARKET: DEALS, JANUARY 2020–JUNE 2023
10.9.3 OTHER DEVELOPMENTS
TABLE 223 PEPTIDE SYNTHESIS MARKET: OTHER DEVELOPMENTS, JANUARY 2020–JUNE 2023
11 COMPANY PROFILES
11.1 KEY PLAYERS
(Business Overview, Products & Services offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats))*
11.1.1 THERMO FISHER SCIENTIFIC
TABLE 224 THERMO FISHER SCIENTIFIC: BUSINESS OVERVIEW
FIGURE 34 THERMO FISHER SCIENTIFIC: COMPANY SNAPSHOT (2022)
11.1.2 MERCK KGAA
TABLE 225 MERCK KGAA: BUSINESS OVERVIEW
FIGURE 35 MERCK KGAA: COMPANY SNAPSHOT (2022)
11.1.3 GENSCRIPT BIOTECH CORPORATION
TABLE 226 GENSCRIPT BIOTECH CORPORATION: BUSINESS OVERVIEW
FIGURE 36 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2022)
11.1.4 BACHEM HOLDING AG
TABLE 227 BACHEM HOLDING AG: BUSINESS OVERVIEW
FIGURE 37 BACHEM HOLDING AG: COMPANY SNAPSHOT (2022)
11.1.5 KANEKA CORPORATION
TABLE 228 KANEKA CORPORATION: BUSINESS OVERVIEW
FIGURE 38 KANEKA CORPORATION: COMPANY SNAPSHOT (2022)
11.1.6 BIOTAGE AB
TABLE 229 BIOTAGE AB: BUSINESS OVERVIEW
FIGURE 39 BIOTAGE AB: COMPANY SNAPSHOT (2022)
11.1.7 SYNGENE INTERNATIONAL LIMITED
TABLE 230 SYNGENE INTERNATIONAL LIMITED: BUSINESS OVERVIEW
FIGURE 40 SYNGENE INTERNATIONAL LIMITED: COMPANY SNAPSHOT (2022)
11.1.8 MESA LABORATORIES, INC.
TABLE 231 MESA LABORATORIES, INC.: BUSINESS OVERVIEW
FIGURE 41 MESA LABORATORIES, INC.: COMPANY SNAPSHOT (2022)
11.1.9 CEM CORPORATION
TABLE 232 CEM CORPORATION: BUSINESS OVERVIEW
11.1.10 PROTEOGENIX
TABLE 233 PROTEOGENIX: BUSINESS OVERVIEW
11.1.11 BIO-SYNTHESIS INC.
TABLE 234 BIO-SYNTHESIS INC.: BUSINESS OVERVIEW
11.1.12 DALTON PHARMA SERVICES
TABLE 235 DALTON PHARMA SERVICES: BUSINESS OVERVIEW
11.1.13 AAPPTEC
TABLE 236 AAPPTEC: BUSINESS OVERVIEW
11.1.14 VIVITIDE
TABLE 237 VIVITIDE: BUSINESS OVERVIEW
11.1.15 ANYGEN CO., LTD.
TABLE 238 ANYGEN CO., LTD.: BUSINESS OVERVIEW
11.2 OTHER PLAYERS
11.2.1 CSBIO
11.2.2 ADVANCED CHEMTECH
11.2.3 LUXEMBOURG BIO TECHNOLOGIES LTD.
11.2.4 JPT PEPTIDE TECHNOLOGIES GMBH
11.2.5 AMBIOPHARM INC.
11.2.6 AURIGENE PHARMACEUTICAL SERVICES LTD.
11.2.7 CORDENPHARMA INTERNATIONAL
11.2.8 CHEMPEP INC.
11.2.9 CPC SCIENTIFIC INC.
11.2.10 PUROLITE PVT. LTD.
*Details on Business Overview, Products & Services offered, Recent Developments, and MnM View (Key strengths/Right to Win, Strategic Choices Made, and Weaknesses and Competitive Threats) might not be captured in case of unlisted companies.
12 APPENDIX
12.1 DISCUSSION GUIDE
12.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.3 CUSTOMIZATION OPTIONS
12.4 RELATED REPORTS
12.5 AUTHOR DETAILS
